Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-02 4:13 pm Purchase | 2020-12-31 | 13G | Beam Therapeutics Inc. BEAM | ARCH Venture Fund IX L.P. | 8,243,039 13.500% | 8,243,039 (New Position) | Filing History |
| 2021-01-19 1:25 pm Sale | 2021-01-08 | 13D | Karuna Therapeutics, Inc. KRTX | ARCH Venture Fund IX L.P. | 3,082,635 11.500% | -280,237 (-8.33%) | Filing History |
| 2020-07-29 3:50 pm Unchanged | 2020-07-08 | 13D | Vir Biotechnology, Inc. VIR | ARCH Venture Fund IX L.P. | 28,666,663 23.000% | 0 (Unchanged) | Filing History |